A rare case of catastrophic antiphospholipid syndrome triggered by estrogen-containing oral contraceptives in a patient with double heterozygous factor V Leiden and prothrombin G20210A mutations

Am J Hematol. 2022 Feb 1;97(2):239-242. doi: 10.1002/ajh.26138. Epub 2021 Mar 20.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antiphospholipid Syndrome / chemically induced*
  • Antiphospholipid Syndrome / genetics
  • Contraceptives, Oral / adverse effects*
  • Estrogens / adverse effects*
  • Factor V / genetics*
  • Female
  • Humans
  • Point Mutation / drug effects
  • Prothrombin / genetics*

Substances

  • Contraceptives, Oral
  • Estrogens
  • factor V Leiden
  • Factor V
  • Prothrombin